Have a feature idea you'd love to see implemented? Let us know!
Back to LGND overview

LGND Ligand Pharmaceuticals PE ratio, current and historical analysis

As of Dec 6, 2024, the Ligand Pharmaceuticals stock's PE ratio is 47.28. This results from the current EPS of $2.64 and stock price of $124.83. The P/E ratio has an increase of 73% from the past four quarters average of 27.4.

LGND PE ratio history

How has LGND's PE ratio performed in the past

The PE ratio of Ligand Pharmaceuticals has averaged 87.62 over the last ten years. The current PE ratio of 47.28 is 46% below the historical average. Over the past ten years, LGND's PE ratio was at its highest in the Sep 2020 quarter at 794.33, when the stock price was $95.32 and the EPS was $0.12. The lowest value was in the Dec 2019 quarter, when it reached 3.15 with a price of $104.29 and an EPS of $33.13.

Average
87.62
Median
41.41
Minimum
3.15
Maximum
794.33

Ligand Pharmaceuticals PE ratio by year

Maximum annual decrease: -91.22% in 2018

Year PE ratio Change
2023 23.65 N/A
2022 N/A N/A
2021 44.9 N/A
2020 N/A N/A
2019 3.15 -84.28%
2018 20.04 -91.22%
2017 228.22 N/A
2016 N/A N/A
2015 9.34 -89.64%
2014 90.19 -3.98%

LGND average PE ratio chart

What is the average PE ratio of LGND for the past years

The current PE ratio of LGND is greater than its 3-year historical average, but it is below the 5 and 10-year averages.

3-year avg
43.88
5-year avg
95.34
10-year avg
87.62
15-year avg
95.5

LGND PE vs peers

What is LGND's PE ratio compared to its peers

LGND's PE ratio is lower than its peer stocks LLY and BAX, but it is greater than JNJ's and MRK's. Ligand Pharmaceuticals is presently trading at a higher PE ratio (47.28) than its peer group average of 40.74.

Stock name PE ratio Market cap
MRK Merck & Co Inc 21.52 $260.78B
JNJ Johnson & Johnson 24.76 $359.48B
PFE Pfizer Inc 33.86 $145.81B
AMGN Amgen Inc 34.55 $146.52B
LGND Ligand Pharmaceuticals Inc 47.28 $2.36B
LLY ELI LILLY & Co 88.99 $784.81B
BAX Baxter International Inc 151.43 $16.24B
BMY Bristol Myers Squibb Co N/A $120.43B

Frequently asked questions

What is Ligand Pharmaceuticals's PE ratio?

The price to earnings ratio for LGND stock is 47.28 as of Dec 6, 2024.

What is the 3-year average PE ratio for Ligand Pharmaceuticals (LGND)?

The 3-year average PE ratio for LGND stock is 43.88.

What is the 5-year average PE ratio for Ligand Pharmaceuticals (LGND)?

The 5-year average PE ratio for LGND stock is 95.34.

What is the highest PE ratio for LGND?

The highest quarterly PE ratio in the last ten years has been 794.33 and it was in the Sep 2020 quarter.

How does the current PE ratio for LGND compare to its historical average?

LGND's price to earnings ratio is currently 46% below its 10-year historical average.

How is LGND's PE ratio calculated (Ligand Pharmaceuticals PE ratio formula)?

The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Dec 6, 2024), Ligand Pharmaceuticals's stock price is $124.83. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $2.64. Therefore, Ligand Pharmaceuticals's P/E ratio for today is 47.28. PE RATIO(47.28) = STOCK PRICE($124.83) / TTM EPS($2.64)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.